Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.3625
-0.0113 (-3.02%)
Official Closing Price
Updated: 8:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
36
37
Next >
Small Pharma, GH Research Among Top Psychedelic Movers Of Today
February 23, 2022
GAINERS: Small Pharma (OTC:
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2022
February 22, 2022
GAINERS: LOSERS: Mindset Pharma (OTC:
Via
Benzinga
Cybin Reports Adelia Milestone
February 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study
February 22, 2022
Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. ...
Via
Benzinga
Cybin (NEO: CYBN) (NYSE American: CYBN) Reports Adelia Milestone
February 22, 2022
Via
Investor Brand Network
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
February 21, 2022
An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt
Via
Talk Markets
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
February 18, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Achievement of Additional Adelia Milestone
February 18, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievement
February 18, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From February 17, 2022
February 17, 2022
GAINERS: Mindset Pharma (OTC:
Via
Benzinga
Cybin Chopra Foundation Team To Advance Psychedelics In Mental Health
February 16, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Aegis Virtual Conference
February 16, 2022
Via
Investor Brand Network
Cybin (NYSE American: CYBN) (NEO: CYBN), Chopra Foundation Team to Advance Psychedelics in Mental Health
February 16, 2022
Via
Investor Brand Network
Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education
February 15, 2022
Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) ...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2022
February 15, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
Cybin to Participate in Aegis Virtual Conference on February 24, 2022
February 15, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), The Chopra Foundation Partner to Uncover Potential of Psychedelic Therapies in Mental Health
February 15, 2022
Via
Investor Brand Network
Cybin Turning Psychedelics-to-Therapeutics(TM) Vision Into Reality
February 15, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Turning Psychedelics-to-Therapeutics(TM) Vision into Reality
February 15, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From February 14, 2022
February 14, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Working on Turning Psychedelics-to-Therapeutics(TM) Vision into Reality
February 14, 2022
Via
Investor Brand Network
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
February 14, 2022
Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psy...
Via
Benzinga
Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind'
February 14, 2022
The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a position ...
Via
Benzinga
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today
February 11, 2022
GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI...
Via
Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
February 10, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89
Via
Benzinga
Cybin Granted US Patent Covering Lead Proprietary Compound
February 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin (NEO: CYBN) (NYSE American: CYBN) Granted US Patent Covering Lead Proprietary Compound
February 10, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights
February 10, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From February 9, 2022
February 09, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.